Friday, July 28, 2006
Dieting More of a Problem Than a Solution?
Many more people than previously acknowledged may be living lives divorced from a happy and healthy relationship with food and eating. Long-term dieters are like drug addicts - their next go is definitely going to be their last but somehow it never is. Increasing amounts of research indicate that dieting is more often a contributor to long-term eating and weight issues than it is a passport to lasting and relaxed weight control. Whilst repeated dieting does not automatically lead on to the very serious eating disorders of anorexia and bulimia, constant unhappiness with eating and self-image can certainly be harmful to self-esteem and, indeed, physical and mental health. Yale University's Prof. Kelly Brownell coined the notion of Yo-Yo Dieting 20 years ago. The research was a major breakthrough into realizing the limitations of interfering too much with a natural relationship with food and eating. Yo-Yo Dieting is the widely understood notion of periods of crash weight reduction being followed by periods of weight regain once the artificial eating regime is relaxed. Subsequent studies have indicated that major health risks, particularly of heart disease, are associated with these dieting cycles. Now, new research by a weight-control charity suggests that many more people than previously recognized are living their lives dominated by anxieties over eating and dieting. The Weight Foundation says that obsessive dieting is to blame for great misery and that too little help is on offer for individuals who spend their lives locked into depressing and often unhealthy dieting regimes. For many women, the panicky run-up to peak holiday time - and also the Thanksgiving period - are triggers for fresh cycles of self-starvation, with the lost weight often creeping back on. However, The Weight Foundation is discovering that the extent of the worldwide dieting misery is much wider than these weight-loss and regain rituals. The research being conducted by the charity's founder through the UK's Manchester Metropolitan University is shedding light on the millions of dieters worldwide who suffer long-term distress but do not undergo any dramatic swings in weight. "The accepted pattern of dieting is what has been called Yo-Yo-ing," explains Evans, a 46 year old Cambridge University social sciences graduate, professional motivational trainer and private therapist. "Instead, we call this Swinger dieting because we find whether and how quickly weight returns depends on many factors and is not automatic like a Yo-Yo. However, the more you look at what is actually going on in the privacy of people's own homes, this is just the tip of the dieting iceberg." Flatliner dieting is identified as being a constant battle between "good" and "bad" foods, with people varying between treating and punishing themselves with food. These mini-dieting cycles can be packed within as short a time as a single day. The term Flatliner refers both to the lack of any jagged peaks of weight gain and loss and also to the emotional flatness and misery usually experienced with this lifestyle. There is constant tension between overeating and self-denial. Lifer dieting refers to people who never really come off a diet at all, even though they may swap diets now and then. Lifers fear that breaking their strict eating regime for just a single day might spell disaster. Occasions such as weddings and family gatherings are times of high anxiety. Evans says, "The majority of research to date on eating and dieting problems has tended to concentrate on the extreme areas of Anorexia and Bulimia. What we are finding, particularly horrible as these conditions are, is that there are potentially huge numbers of dieters experiencing great distress." As with all unrecognized conditions, many of these people suffer in silence, without understanding or support. The Weight Foundation is referring to all types of dieting which tend to dominate an individuals' lifestyles as Hardcore Dieting. The charity is seeking to understand what pressures and motivations hold obsessive dieting behavior in place and is finding in both the U.S and the UK that there is a widespread cultural acceptance that a dieting lifestyle is the morally correct lifestyle. It is Evans' goal to develop an international network of committed individuals who can mentor dieters to move away from depressing and destructive habits. The philosophy is that by treating food and eating as mainly just a necessity of life, weight will find its natural – normally lighter – level. "The key difference between happily slim people and unhappily overweight individuals is that, for the former, food plays a very small part in their lives." "Dieting can often make people overweight and it will always make them unhappy. The key to lasting weight control is to enjoy a healthy and natural relationship with food. It is only by developing a thorough understanding of Hardcore Dieting that this message will stop falling on deaf ears," says Evans. The Weight Foundation's website features The Hardcore Dieting Index, a self-diagnostic questionnaire for dieters. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Counterfeit drugs are a growing concern
Criminal organizations have found yet another way to make money: counterfeit prescription drugs, a growing problem that is concerning drug companies and policymakers alike. In 2003, 10 percent of all medications sold worldwide were counterfeit, Rep. Mike Rogers, R-Mich., said at a briefing this week. That's equal to $32 billion of the drug industry. "Technology has allowed criminals to counterfeit drugs and work them into the system here in America," Rogers said. He added that the Food and Drug Administration was originally created to help prevent counterfeiting, and the United States has one of the safest drug systems in the world. "(Counterfeiting) used to be a problem that was confined to developing countries. We're now seeing it in one of the safest and most regulated countries in the world," John Theriault, vice president of security at Pfizer Inc., told United Press International. "It's clearly much worse than it was five years ago." According to an investigation conducted by "Dateline NBC" shown at the briefing, the counterfeit drug market is incredibly profitable. Counterfeiters can sell phony prescriptions for $1 in instances where every real pill would cost $8 at wholesale. A company could import $1.5 million pills a year, resulting in a $10 million profit. Even experts who were brought in by the "Dateline" investigation had trouble distinguishing good counterfeit pills from the real ones. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Importing prescription drugs is not the solution
Baltimore Mayor Martin O'Malley announced recently in his gubernatorial campaign that he will consider buying prescription drugs from Canada and abroad as a way to reduce health care costs for Marylanders. But that policy can potentially harm both consumers and the economics of drug creation and sale in the United States. Those unsolicited and poorly worded offers for Cialis and Viagra in our e-mail inboxes say it all. Drug re-importation is one situation where the invisible hand will not solve the problem. The key prefix is the "re-" in reimportation. The United States develops, creates and produces the bulk of the world's drugs. Foreign governments legally purchase drugs from American companies at discount prices and then set their own prices at home (translation: price controls). Were Maryland to allow drug re-importation, American firms would continue to assume the worldwide burden of drug research and development but at a profit margin that did not take those efforts into account. And how does Mayor O'Malley plan to ensure that drugs coming in are safe? This policy move cannot just be made in isolation. Federal approval is required. Further, when American-produced prescription drugs make their way back into this country, they will have passed through multiple hands, increasing the risk of tampering and counterfeiting. To guarantee drug safety, the Food and Drug Administration would have to investigate (and test) drugs for tampering and counterfeiting, which would create a heavier government and taxpayer burden and ultimately a less favorable environment for the creation of effective medicines. The FDA does not regulate drugs obtained in foreign markets, and describes the medical and economic drawbacks of using these drugs on its Web site. Randall W. Lutter, Ph.D., FDA's associate commissioner for policy and planning told this to would-be re-importer Steven M. Saxe, director of the Washington State Board of Pharmacy: "FDA is very concerned about the safety risks associated with the importation of prescription drugs from foreign countries. In our experience, many drugs obtained from foreign sources that are represented as U.S.-approved prescription drugs are of unknown origin and quality." By law, if a prescription drug is originally manufactured in this country and exported, only the United States manufacturer may import the drug back into the United States. In order for O'Malley to push through what he proposes, he would need to obtain a waiver from the FDA, which is unlikely due to the agency's consistent refusal to approve such applications elsewhere in the United States. The FDA is aware of patients' concerns about access to effective, low-cost medication. Lutter said the FDA is working to change "our regulations to reduce litigation that unnecessarily delays access to more affordable generic drugs, and doubling the annual number of generic drug approvals over the last five years." As an alternative, in the meantime, numerous direct patient assistance programs exist to help mitigate costs for consumers, such as those administered by Lilly, Pfizer and the Partnership for Prescription Assistance in Maryland. Living in America is a trade-off where the prescription drug market is concerned and not necessarily a good one. We have a broad range of effective, cutting-edge choices, but many essential medications are pricey because we shoulder the majority of research and development worldwide. As a result, right or wrong, we aren't just paying for the pill itself; we also pay for its years of testing and research and for pills that never reach the market. But buying medicine from abroad is not the answer. The regulatory machinery that would be required to ensure the safety of imported medicine would be expensive, lengthy to create and erase any potential price benefits. The problem of high drug prices can only begin to be solved when other countries start to devote more funds to research and development and pharmaceutical companies here price brand-name prescriptions more consistently. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Nicotine drink
An American nicotine drink being marketed as a cigarette substitute would only be sold with a prescription if it hit the shelves in Canada, according to Health Canada. Health Canada spokeswoman Nathalie Lalonde said it had previously stated that Nic Lite would fall under the definition of a natural health product because nicotine is a natural chemical substance derived from tobacco plants. Products containing nicotine with a dose equal or lower than four milligrams per serving - equivalent to the amount found in Nic Lite - are regulated as over the counter natural health products. "However, this only applies to certain dosage forms, such as gums and lozenges, and not products in liquid form (such as Nic Lite)," Lalonde wrote in an e-mail to The Canadian Press. Lalonde said all health products must also undergo a thorough pre-market review by Health Canada before they're approved for sale. "Only where there is sufficient evidence supporting the safe and effective use of a product will the product be authorized for sale in Canada," Lalonde wrote. Nic Lite is a lemon-flavoured drink that contains organic nicotine equivalent to the amount found in two cigarettes. Joseph Knight, CEO of California-based Nico Worldwide Inc., the makers of Nic Lite, said that his company has filed an application to Health Canada to bring the product to Canada. "We're hoping that in the next two to three months we would have our clearances in place," Knight told The Canadian Press in a phone interview last week from Oxnard, Calif. Knight said Nic Lite was designed to be used by smokers to help them when they can't smoke. The product is also being touted as a way to cope with smoking bans. In a statement released in June, the makers of Nic Lite said they plan to roll out the product in more than 50 U.S. airports, targeting nicotine-addicted airline passengers facing smoke-free flights and long periods where they may be unable to light up. But Nico Worldwide Inc. may have been dealt a blow in distributing the product in the United States. The U.S. Food and Drug Administration told the company in June that Nic Lite doesn't meet the definition of a dietary supplement. "The product is considered an unapproved new drug," FDA spokeswoman Laura Alvey wrote in an e-mail to The Canadian Press. "The company is in violation of the (Food Drug and Cosmetic) Act in continuing to market the product as a dietary supplement." Nico Worldwide had cited a 1993 New England Journal of Medicine article which stated that nicotine is a naturally occurring compound in many vegetables including cauliflower, eggplant and tomatoes, to support its dietary supplement claim. Knight has said the FDA originally approved Nic Lite in 2004 and that his company's lawyers plan to meet with the government agency in Washington. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Thursday, July 27, 2006
Cialis Means Toughness
Erectile dysfunction formerly called impotency is not a new subject at all to discuss. It is a problem, which our first forefather honorable Mr. Adam might also had faced at some point of time. What I want to say is that it is not a new problem. I have stayed with the mankind since the beginning of life on this earth. Now, the point to be discussed is what erectile dysfunction is and what causes it. Erectile dysfunction (ED) also recognized as impotence, is the lack of ability to get or uphold an erected penis for satisfactory sexual activity. Erectile dysfunction is different from other circumstances that hamper with successful sexual intercourse, such as lack of sexual desire and problems with ejaculation and orgasm. It can occur at any age but it is more common in the men above the age of 65. An occasional episode of erectile dysfunction happens to most men and is normal. As man's age increases, just like he experiences changes in his other body parts, it's also normal to experience changes in his erectile function also. Erections may take longer to develop, may not be as rigid or may require more direct stimulation to be achieved. Men may also observe that his orgasms are less passionate, the quantity of ejaculated semen is reduced and revival time increases between erections. It is estimated that that erectile dysfunction affects 30 million men in United States only. The penis contains two cylindrical, sponge-like structures that run along its length, parallel to the tube that carries semen and urine. When a man becomes sexually aroused, nerve impulses cause the blood flow to the cylinders to enlarge about seven times the regular amount. This sudden influx of blood expands the sponge-like structures and produces an erection by straightening and stiffening the penis. Continued sexual arousal or excitation maintains the higher rate of blood flow, keeping the erection firm. After ejaculation, or when the sexual excitation passes, the excess blood drains out of the spongy tissue, and the penis returns to its non-erected size and shape. Cialis, or Super Viagra, is used to treat erectile dysfunction. Cialis (tadalafil) is an oral treatment for erectile dysfunction. Cialis is offered as film-coated, almond-shaped tablets for oral usage. Each tablet contains 5, 10, or 20 mg of tadalafil. Cialis is known as "the weekender pill" for its long-lasting strength. This is the name given to cialis by the French people. It works exactly like viagra by inhibiting an enzyme called phosphodiesterase, which releases Nitric Oxide from nerve endings and endothelium causing relaxation of smooth muscle and hence penile erection. This is a product developed by Eli Lilly and ICOS and it was launched under the trade name of the product called Tadalafil launched in the market in 2003. Cialis has a power for around 36 hours in contrast to that of Viagra, which is something like 4 hours that means that a person can take the medicine and can anticipate having erection at a time much later than the time of use. In recent trials, it was discovered that 60.4 percent of men who took Cialis succeeded in having sex up to 36 hours later. There is no stipulation of empty or full stomach because this does not affect cialis's performance. Men with ED due to some arterial disorders will benefit the most. There is a widely spread myth that a person as soon as taking the drug will have erection but that is not the case. It starts taking action only when a person gets some sexual stimulation or in other words, he needs to be seduced. In this way it can start is action within 16 minutes for some men and for most within about 30 but not more than that. The recommended dose of Cialis is 20 mg, taken prior to anticipated sexual activity. The maximum recommended Cialis dosing frequency is once per day. Cialis may be taken between 30 minutes and 36 hours prior to anticipated sexual activity. Patients may initiate sexual activity at varying time points relative to Cialis dosing in order to determine their own optimal window of responsiveness. The Cialis dose may be lowered to 10 mg based on individual response and tolerability. Cialis may be taken without regard to food. Cialis Dosage adjustments are not required in elderly patients. Dosage recommendations described in "Use in adult men" apply to elderly men. However, Cialis should not be taken in those cases where sexual activity is not advisable because of their underlying cardiovascular status (heart condition). Patients should inform their doctors about any heart problems that they have experienced prior to taking Cialis. The most common side effects with cialis are headache, indigestion, vision changes, muscle aches, flushing, and stuffy or runny nose. These side effects usually go away after a few hours. Patients who get back pain and muscle aches usually get it 12 to 24 hours after taking cialis. Back pain and muscle aches usually go away by themselves within 48 hours. Cialis may rarely cause an erection that won't go away (Priapism). If you get an erection that lasts more than 4 hours, get medical help right away. Priapism must be treated as soon as possible or lasting damage can happen to your penis including the inability to have erections. Cialis is also available through online Cialis pharmacy stores. Now people don't have to go to their doctors and answer their embarrassing questions because they can buy Cialis from an online cialis pharmacy. Cheap Cialis is available their only on the prescription basis. But some of these cheap cialis pharmacies may be fraud. He reason is simple; because they sell dugs cheaper then original rates they might compromise with the quality of the medicine. So people need to be aware of those online cialis shops, which sell cheap cialis as an OTC dug i.e. without any prior consultation or prescription. Any comments and /or suggestions will be highly appreciated. Please note that this article is not a substitute for medical advice. Labels: No Prescription, Online Pharmacy, Prescription Drugs
New Alternative Therapy
Created in the Amazonian forest, by a Brazilian monk, a new natural treatment to cure and to prevent cancer, seems to be an interesting alternative in the fight against cancer. The priest affirms, he has obtained real results in several types to cancer : cancer of breast, cancer of uterus, cancer of stomach, cancer of skin, cancer of prostate, etc. The formula is simple, cheap and easy to prepare it in house and even though extensive clinical studies do not exist on this procedure, it seems to be a sensible alternative to try. ALOE Vera One of the components of the formula is Aloe Vera (sábila) whose medicinal properties have been investigated for a long time : "It has been proved that Aloe Vera is effective in cancer in animals. In fact, in 1992, the U.S. Department of Agriculture approved the use of Aloe Vera for the treatment of soft tissue cancer in animals as well as feline leukaemia. There is strong scientific proof that, in vitro, Aloe Vera suppresses the growing of cancer tumour, stimulates immune system response, raises tumour necrosis levels, and promotes healthy tissue". "Aloe Vera helps to lower the damage done to the body by treatments such as radiation and chemotherapy, which destroy healthy immune system cells that are very important for the body's recovery. With the use of Aloe Vera, the immune system is boosted, tumors shrink, metastases are reduced so the cancer does not spread, and new" "In 1997, University of San Antonio researcher Jeremiah Herlihy, Ph.D., conducted a study to observe any negative effects of drinking aloe daily. Rather than exhibiting negative effects, however, test animals receiving daily aloe showed a remarkable reduction in leukemia, heart disease, and kidney disease. Dr. Herlihy concluded, "We found no indication of harm done to the rats even at high levels." In fact, the aloe-drinking animals actually lived 25 percent longer than those in the control group" Other components are bee honey and "cañazo" (rum, or any distilled liqueur). HONEY Medicine may be increasingly high-tech, but the latest wonder treatment which is being offered to patients is — honey. Last week, it was announced that bandages soaked in manuka honey are to be given to mouth cancer patients at the Christie Hospital in Manchester to reduce their chances of contracting the MRSA super bug and to lessen wound inflammation following surgery. This is just the latest study investigating this particular type of honey's healing powers. It is used routinely at the Manchester Royal Infirmary for dressing wounds, and other research has found it can fight gum disease, ease digestive problems and soothe sore throats. All honey contains hydrogen peroxide, a substance once used as a wound disinfectant in hospitals — it comes from an enzyme that bees add to nectar. It also contains the enzyme glucose oxidase, which boosts its anti-bacterial properties. This was recognised by the ancient Egyptians and Greeks, who used honey to help heal burns and sores. Aloe, bee honey and rum are mixed and a syrup is obtained that must be consumed daily. It is important to use "fresh pulp of the plant Aloe Vera, including the rind. (to retire the thorns). Not to use commercial extracts of Aloe Vera. In order to avoid the poisonous effect of the plant Aloe Vera, the treatment must be alternated : 10 days of treatment, 10 days free or of rest. Never long treatments. The treatment can be used single or complementing chemotherapy processes. An ample and detailed description of the treatment can be found at : "The Miracle of Sharing.Org" Other Diseases This treatment also can be useful for autoimmune and digestive diseases. (irritable bowl syndrome, ulcerative colitis, esophagitis, peptic ulcer, rheumatoid arthritis, osteoarthritis, mouth lesions, sore-throat, lupus, etc.) Remark All information is general in nature and is not intended to be used as a substitute for appropriate professional advice and the reader assumes all risks from the use, non use or misuse of this information. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Wednesday, July 26, 2006
EXPOPHARM 2006
Once again, this year's EXPOPHARM in Munich will be stressing its importance as a European leading trade fair for the drugs and pharmacy market. From 21st to 24th September 2006, around 450 exhibitors from 17 nations will be presenting their products and services on approx. 24,000 square metres of exhibition floor. For the first time in its over 50 years´ existence, EXPOPHARM has been booked up for weeks. Visitors´ interest has been developing in parallel to the extremely positive feedback of the exhibitors. Over 20,000 domestic and overseas visitors are expected in halls C1 to C4 of Munich New Fair Ground. The number of visitors attending seminars held at the same time as the fair should also exceed expectations this year. Last year, providers recorded over 1,500 participants. Meanwhile, the complete directory of exhibitors is already online. Visitors and interested parties can not only get company information, but also prepare for their visit with an electronic trade fair planner. This personal visit programme can be stored, updated and called at any time. A large selection of information, e.g. exhibitor newsletter, travel tips, accommodation offers, and general information on the Bavarian Land Capital can be found at www.expopharm.de. At the same time as EXPOPHARM, the German Pharmacists Day 2006, which like the fair, is being held against the background of current health political developments, will be taking place in the International Congress Centre. On the eve of the opening, a media prize endowed with a total of 20,000 euros will be granted for the second time. For further information and pictures, please check out www.expopharm.de We will be pleased to provide further information as well as pictures for you: EXPOPHARM Press Office, Carl-Mannich-Straße 26, 65760 Eschborn, Germany Phone: +49 – 6196 – 928 413, Fax: +49 – 6196 – 928 404, E-mail: pressestelle@wuv.aponet.de www.expopharm.de Labels: No Prescription, Online Pharmacy, Prescription Drugs
Accutane's broader use, side effects lead to costly, time-consuming U.S. restrictions
Don't dawdle on the way to your local pharmacy with that Accutane prescription. That's the hard lesson Lynette Yarnick of Indiana, Pa., learned in May when she tried to obtain the potent anti-acne drug for her 17-year-old son Joey at a local CVS drugstore, only to be told it was out of stock. When she returned a week later, "they said the prescription had expired and I'd have to make an appointment with Joey's dermatologist to start the process all over again," Mrs. Yarnick said. The Yarnicks are farmers and don't have insurance, so the new doctor's appointment cost them an extra $300 -- and disrupted her son's treatment. "It was such a shame," she added, "because Accutane has just been a miracle drug for Joey." That hoop that Mrs. Yarnick and her son had to jump through is just one of many erected since March to strictly control isotretinoin, the generic name for Accutane, which has become the gold standard for people suffering from acne since its approval by the U.S. Food and Drug Administration 23 years ago. Accutane was originally formulated for severe acne that is resistant to over-the-counter and prescription-only remedies: benzoyl peroxide, salicyclic acid, Retin-A and antibiotics. Increasingly, though, dermatologists have been prescribing Accutane for milder forms of acne, which afflicts nearly 85 percent of people 18 to 24 years old. Because Accutane has severe side effects, including a risk of birth defects, there always have been restrictions on its use. Monthly blood tests monitoring liver function, cholesterol and other conditions have been required for both men and women, as well as pregnancy tests for women of childbearing potential. Accutane can cause miscarriages, stillborn babies and severe birth defects, including heart and central nervous system abnormalities, deformed limbs and heads, asymmetrical facial features and mental retardation. Some researchers suspect it may lead to depression or suicide, although others say the data is inconclusive. But under the new, federally mandated "iPledge" program, patients must undergo lengthy counseling about the drug and enroll in an online registry to answer questions about its use and risks, while medical staffers must spend increased time online recording lab results and on the phone with iPledge representatives and pharmacists. Sometimes, though, staffers have been put on hold for hours, and if they don't meet certain deadlines, the patient's case is eliminated from the iPledge system and they must start the process again. In fact, dermatologists say iPledge has proved to be so cumbersome and complicated that a number of them -- both nationally and in Pittsburgh -- no longer prescribe the drug. Before iPledge went into effect March 1, dermatologists wrote 170,000 prescriptions a month. In the 41/2 months since, according to iPledge, 150,000 Accutane users have been entered into the program. "The iPledge program is killing us," said Monroeville dermatologist Lisa Pawelski. "I have stopped prescribing it for women of childbearing potential until the mess is fixed, but I do not see much happening toward a fix." In recent years, some drug safety advocates and a Michigan congressman whose son committed suicide while taking Accutane have sought to ban or severely restrict the drug, complaining that it is overprescribed. The FDA has declined to ban it, but in March, at the agency's urging, four manufacturers hired Covance Inc., a global biotech company, to create iPledge to control its distribution and thoroughly educate patients about possible side effects. The result seems to have satisfied no one. While FDA officials have said they hope iPledge will reduce pregnancies among Accutane users to zero, early indications aren't encouraging. Since March, "we've received calls from women on Accutane who have become pregnant and who were in the iPledge system," said Dr. Christina Chambers, president of the Organization of Teratology Information Specialists, a birth defects prevention group. Meanwhile, the American Academy of Dermatology, which strenuously lobbied to delay iPledge until flaws in its computer-based program were worked out, says that startup problems have created numerous delays in treatment. Dr. Pawelski's medical assistant was put on hold for four hours before she could reach an iPledge official to clear up a problem with one prescription. Since then, iPledge phone waiting times have gone down to 20 minutes, "but that's still unacceptable," Dr. Pawelski said. Also, because iPledge requires that 30 days elapse between doctors' visits, a patient who can't fill an Accutane prescription within seven days of receiving it at a doctor's office is "locked out" of iPledge's computer system, and must wait 23 more days before seeing a doctor for a new prescription. "It's infuriating to me that, after 14 years of post-secondary training and 14 additional years of experience in medical practice, not to mention a zero percent pregnancy rate, I have to now comply with this poorly written, time-wasting, confusing, mockery of a program," Dr. Pawelski said. "It's also thoroughly unjust to the women whom I cannot now treat." Even those who still prescribe Accutane are unhappy with iPledge. Dr. Douglas Kress, a pediatric dermatologist with Children's Hospital of Pittsburgh who also has a private practice,, said his academic position gives him access to enough staff to maneuver through iPledge's requirements, which he nonetheless calls "ridiculous." The company running iPledge only had "maybe two operators on staff at the beginning for who knows how many calls. "It's almost as though the system is being designed to fail so the FDA will ban it," he said. Not so, said Dr. Peter A. Gross, who chaired the FDA drug safety panel that mandated iPledge. "Our job was to do what's best for the patient. If that meant a little bit more time with the patient to ensure appropriate and safe delivery of the drug, so be it," said Dr. Gross, who chairs the department of internal medicine at Hackensack University Medical Center in New Jersey. If anything, Dr. Gross said, he would have liked to see the FDA re-examine the risks versus the benefits of Accutane and a host of other popular drugs that were approved years ago, because it's possible that many of the side effects were not known then. That proposal to FDA officials "didn't go anywhere." "The FDA is often accused of letting drugs out there that cause all sorts of serious side effects, but then when they do something, they're criticized on the other side. They're in a no-win situation," he said. For example, the book that patients are required to read -- about an hour's worth of material -- before receiving a prescription is "huge, daunting," said Dr. Melanie Costa, who has a dermatology practice in Friendship. "There are amazing things in that book," he said. "There's talk about possible association with diabetes and all kinds of bizarre things. They really pile on the overly frightening rhetoric." Sharon Mohale, a certified physician's assistant in Dr. Kress' office, questions the age-inappropriateness of some of iPledge's requirements. Some Accutane patients are as young as 12, she said, "and they have to go online and answer questions like which form of birth control they should use and what they should do if a condom breaks." Another sticking point is making boys and women who can't get pregnant subject to iPledge's rules. Jackie Funt, who manages her husband's Mt. Lebanon dermatology practice, said she doesn't understand why teenage boys are required to read an hours' worth of material about pregnancy risks before being allowed to receive the drug. "It doesn't make any sense," she said. On June 12, after being deluged by complaints from dermatologists, eight U.S. senators of both parties wrote Dr. Andrew C. von Eschenbach, the acting head of the FDA, expressing concern about iPledge and urging him to "address the procedural barriers plaguing the operation." An FDA spokeswoman declined to comment on the letter or Dr. von Eschenbach's response. Officials at Covance did not respond to requests for an interview, instead issuing a statement acknowledging "some confusion and delays" in March and April, when large numbers of prescribers and patients registered with iPledge. Staffing has since been increased. Covance will be required to track how many women registered in the iPledge system become pregnant while on Accutane, and make that information public, although no data has been released yet. It's not clear, in fact, how many women have actually gotten pregnant over the years while taking the drug before iPledge was instituted; such reporting has been voluntary. One study by Roche, one of the drug's manufacturers, found that nearly 2,000 women became pregnant while on the drug since its approval nearly 24 years ago, and 383 gave birth. Almost half of those babies had birth defects. Rep. Bart Stupak, a Democrat from Michigan whose teenage son committed suicide while on Accutane, remains skeptical that iPledge will lower those numbers. Mr. Stupak, who held a much-publicized hearing in 2002 on Accutane's dangers, suspects the pregnancy rate among Accutane users is much higher than that, as well as the suicide rate. Already, he claims, there have been reports of pregnancies involving women in the iPledge system. As long as Accutane continues to be prescribed in such high volume, he said, he doubts these kinds of serious side effects can be avoided. "For people who face severe disfigurement from acne, fine. Let those families weigh the options of whether they want to do it. But dermatologists are handing it out like it is candy," he said. It's true that Accutane has become the most widely prescribed acne medication in the country. But Dr. Diane Thiboutot, professor of dermatology at Penn State Milton S. Hershey Medical Center, argued that the FDA is limiting how dermatologists practice medicine. And it's unfair to penalize hundreds of thousands of patients -- men as well as women -- who have benefited from Accutane because a small percentage of women will ignore the warnings. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Tuesday, July 25, 2006
Medicaid Prescription Program Too Costly For Some Seniors
Millions of seniors may soon have to pay out of pocket for prescriptions that used to be covered by Medicare. The new Medicare prescription plan has a coverage gap. The gap varies, but here's what it looks like under the standard Medicare plan: Once drug costs reach $2,250, seniors pay 100 percent of their drug costs, up to $5,100, when Medicare catastrophic coverage kicks in. The people at Medicare suggested seniors keep using their Medicare insurance program, but for some seniors, that is just not an option. Sol Salkovitz said that lately he has come to depend on Medicare to pay for costly medications. Salkovitz's wife had a stroke. Medical expenses pushed her into the Medicare prescription drug coverage gap. So, instead of a co-pay, Salkovitz had to pick up the entire cost of the drug. "How do you say no? How do you skip? You can't skip. You wake up every day and say, 'Thank God I'm here," Salkovitz said. Salkovitz went in search of cheaper drugs and he ended up at Adams Discount Pharmacy. Adams is a cash pharmacy, meaning it accepts no insurance. "We buy it cheaply and only mark it up a few dollars. We keep it at a lower price, a discounted price. The most savings are for generics -- deep discounts," said Adam Shubbar of Adams Discount Pharmacy. But the centers for Medicare and Medicaid services say seniors should not go looking for cheaper drugs, but stick with their Medicare drug card. "You're getting those deep discounts the plan's negotiated. In addition, the plan is tracking what you're spending out of pocket so the plan will notify you when you reach that catastrophic limit," said Nancy O'Conner of the Philadelphia Regional Office for the Centers for Medicare and Medicaid Services. Without using a card, seniors must track the drug expenses themselves and then send copies of the receipts to their Medicare drug plan. But some say that buying pills on the plan is just too expensive. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Monday, July 24, 2006
Leukemia Cancer Drugs May Cause Heart Failure
New drugs used to treat leukemia, including Gleevec, may cause serious heart damage, according to U.S. researchers. The researchers say that people taking the medication should continue to take it, but should also be closely monitored for heart damage. The researchers from Jefferson Medical College in Philadelphia, Tufts University School of Medicine in Boston, University of Texas released the caution of Sunday, after they found evidence that treatment caused heart failure in 10 patients. They say that people taking other drugs in the same class, called tyrosine kinase inhibitors, may also be at risk for heart damage. The drugs have been very successful in treating chronic myelogenous leukemia or CML, in most patients. They have found that 80 to 90 percent of the patients taking the drug were cancer free for at least five years. The drugs have also been successful in treating a rare form of stomach cancer called gastrointestinal stromal tumors or GIST. Thomas Force, who led the investigation, said ""Gleevec is a wonderful drug and patients with these diseases need to be on it. We're trying to call attention to the fact that Gleevec and other similar drugs coming along could have significant side effects on the heart and clinicians need to be aware of this. It's a potential problem because the number of targeted agents is growing rapidly." The researchers tested the drug in lab dishes and found that it appears to be toxic to heart cells. Also, mice treated with Gleevec developed left ventricular dysfunction. This is a key symptom for heart failure. Novartis, the maker of Gleevec said the cases of heart failure were rare. Force said "While the cancer is treated effectively, there will be some percentage of patients who could experience significant left ventricular dysfunction and even heart failure from this." Heart failure will kill half of the patients within 5 years. Novartis said that patients can be successfully treated with two drugs that can help treat the heart failure. These drugs, called ACE inhibitors and carvedilol, can be used as a treatment, but the prognosis for heart failure remains poor. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Medicines designed for one illness have often been used to aid another
You have a sore back and are prescribed an anti-depressant? Don't laugh, it happens more often than you'd think. It's called off-label use, a practice which refers to the use of an approved drug to treat anything outside the scope of the drug's labelling. A friend's mother, for instance, is taking an anti-seizure medication for her chronic pain. As I understand it, anti-depressants may be prescribed to help people quit smoking. And I'm told that in cancer therapy, a drug effective in treating one kind of cancer may be used to treat another even though it wasn't approved for that purpose. Even over-the-counter drugs are used for reasons that are not indicated. Can't sleep? Pop a Gravol at bedtime. According to the Journal of Head and Face Pain, off-label prescribing is not uncommon in treating headaches and is within the current standard of care. Anti-epileptics and newer anti-depressants are treatments that apparently help control chronic headaches -- and they're not even related to painkillers. This past May, an article in the Archives of Internal Medicine shed further light on the practice by reporting an enormous study of 725 million prescriptions written in the U.S. in 2001 (this represented about half of the total number of prescriptions written that year). The authors found that 21% of the total were for off-label usage, the majority of which lacked strong scientific evidence. Looked at more closely, of the 18 million prescriptions for psychiatric drugs in this study, 17 million apparently looked pretty thin evidence-wise. Only 11% of the off-label uses of allergy prescriptions were backed by solid evidence. The three types of drugs most likely to be prescribed off-label are anticonvulsants, tricyclic anti-depressants, and anti-inflammatory pills. Who knew? The study's authors found that some of the off-label uses were logical (an asthma drug prescribed for other lung diseases, for example), but others were for conditions dramatically different from those for which the drug was approved. Off-label drug prescribing is common throughout the world. I read that, in India, pharmacists were concerned that an anti-ulcer drug was used for terminating pregnancy and that in one study, 25% of the drugs prescribed in a French surgical unit were off-label. According to the authors of the study published last May, prescribing off-label "brings greater latitude to turn scientific knowledge into innovative clinical practice." There's nothing legally wrong with it. I'm sure most docs won't prescribe off-label without having confidence in a drug's "other" effectiveness -- from either reading studies or having had experience over the years with a particular treatment. Drug manufacturers are actually not allowed to market a drug for its off-label use, though Health Canada allows companies to report scientific studies in the form of press releases regarding off-label use. But I bet that drug companies would just love to promote off-label use because doing so can dramatically drive drug sales. Just look at how hormone replacement therapy's profits soared in days past when physicians assumed estrogen (originally to prevent osteoporosis) offered heart and stroke protection for post-menopausal women: The "fountain of youth" it promised became a cesspool when studies showed that HRT increased the risk of diseases, including breast cancer. Botulin toxin, approved for the treatment of muscle spasms, was only somewhat profitable before its huge economic success as Botox -- a popular cosmetic anti-wrinkle treatment. There's certainly a dark side to off-label use: For example, one breast cancer drug had been used confidently as a fertility drug until Health Canada warned doctors a few years ago that the drug tripled the risk of fetal abnormalities. The bottom line? Be informed. If the drug recommended to you is for an off-label use, talk frankly to your doctor and address the risks and benefits of the medication. Explore why the doctor feels that particular drug may be more effective than the use of an approved drug. Ask him or her what gives them the confidence to support the off-label use of that drug. It's your body -- and you should know what goes into it. Labels: No Prescription, Online Pharmacy, Prescription Drugs
Sunday, July 23, 2006
serotonin reduces appetite could help in developing safer anti-obesity drugs
A study led by a UT Southwestern Medical Center researcher sheds light on how the brain chemical serotonin, when spurred by diet drugs such as Fen-phen, works to curb appetite. That knowledge could aid in the design of safer anti-obesity drugs nearly a decade after Fen-phen was banned for causing harmful side effects. The study, which tested the effect of several drugs that alter serotonin levels in the brain, found that serotonin activates some neurons and melanocortin-4 receptors, or MC4Rs, to curb appetite and at the same time blocks other neurons that normally act to increase appetite. The dual effect helps explain how such drugs, including Fen-phen, spur weight loss. The finding, available online and in the July 20 issue of Neuron, also reinforces the role of serotonin - a regulator of emotions, mood and sleep - in affecting the brain's melanocortin system, a key molecular pathway that controls body weight. "The more we understand about the pathways and the way serotonergic drugs regulate body weight, the more it one day might lead to harnessing beneficial properties of anti-obesity treatments like Fen-phen and minimizing the harmful side effects," said Dr. Joel Elmquist, professor of internal medicine at UT Southwestern and co-senior author of the study. In the United States, about 66 percent of adults are obese or overweight, as are 16 percent of young people aged 6 to 19, according to the Centers for Disease Control and Prevention. The trend is significant because being overweight or obese increases the risk of harmful health consequences, such as heart disease, stroke, diabetes, non-alcoholic liver disease and death. Drugs that enhance the brain's release of serotonin have helped people lose weight. Fen-phen, which paired fenfluramine with phentermine, had such success. The drug combination, however, also led some patients to develop cardiac complications, Dr. Elmquist said. The drug was removed from the market in 1997. But the mechanisms of how it caused weight loss were never fully determined, he said. So a few years ago, Dr. Elmquist and his research team set out to detail how fenfluramine affected the brain's molecular pathways to reduce appetite. In 2002, they examined the region of the brain's hypothalamus containing the arcuate nucleus, or ARC. In the ARC, drug-induced serotonin activates brain cells called pro-opiomelanocortin neurons, or POMC, which in turn release a hormone that acts on the MC4R to reduce appetite. The team's new study shows how serotonin also simultaneously blocks other neurons, known as NPY/AgRP, from being able to inhibit activity of MC4Rs. By blocking this inhibitory activity, serotonin prevents an increase in appetite. Researchers studied the effect of Fen-phen and other serotonin-inciting drugs on both normal and genetically engineered lean and obese mice. They found that serotonin's dual regulation of POMC and AgRP neurons is necessary to promote weight loss. "The finding increases the understanding of the molecular circuitry that controls body weight in response to changing levels of serotonin," Dr. Elmquist said. "An overarching goal of this understanding, for humans, is to design specific, safe drugs to fight obesity." Dr. Elmquist, who recently left Harvard Medical School, directs the newly formed Center for Hypothalamic Research at UT Southwestern. The center, along with the Taskforce for Obesity Research, a National Institutes of Health Interdisciplinary Research Center, is part of the institution's effort to investigate the causes of obesity, metabolic syndrome and diabetes. Labels: No Prescription, Online Pharmacy, Prescription Drugs
|